{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Valeant Pharmaceuticals International chief executive J Michael Pearson attempts to reassure investors in conference call that steep drop in company's stock price is not indication that its future is no longer bright; attributes stock performance to criticisms it has received over large price increase on its drugs and relationship with specialty pharmacy.", "type_of_material": "News", "word_count": "1060", "lead_paragraph": "J. Michael Pearson, the pharmaceutical company\u2019s chief executive, said in a conference call with investors that the company was strong, despite recent issues.", "pub_date": "2015-11-11T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Valeant Chief Says Issues Stem From Fast Growth", "print_headline": "Valeant Chief Says Issues Stem From Fast Growth "}, "snippet": "J. Michael Pearson, the pharmaceutical company\u2019s chief executive, said in a conference call with investors that the company was strong, despite recent issues.", "multimedia": [{"height": 126, "url": "images/2015/11/11/business/11valeant-web2/11valeant-web2-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/11/business/11valeant-web2/11valeant-web2-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 393, "url": "images/2015/11/11/business/11valeant-web2/11valeant-web2-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "393", "xlarge": "images/2015/11/11/business/11valeant-web2/11valeant-web2-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/11/business/11valeant-web2/11valeant-web2-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/11/business/11valeant-web2/11valeant-web2-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/11/business/valeant-chief-expresses-optimism-about-its-future.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Pearson, John Michael (1959- )", "name": "persons"}, {"rank": "3", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Company Reports", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Philidor Rx Services LLC", "name": "organizations"}], "blog": [], "_id": "5642338b38f0d842ce0a8757", "source": "The New York Times"}